Status:
COMPLETED
Salvage Prostatectomy After Radiotherapy
Lead Sponsor:
University Health Network, Toronto
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the location of the cancer found in the prostate gland after it is removed to the location that was predicted on the MRI scan during biopsy. In this way, we can...
Detailed Description
Two hundred and nineteen thousand new cases of prostate cancer have been projected in the Unites States for 2007, with external beam radiotherapy (EBRT) constituting the mainstay of local therapy for ...
Eligibility Criteria
Inclusion
- Prior enrollment of UHN 05-0641-C
- Histological evidence of cancer on MRI-guided prostate biopsy
- PSA doubling time \> 6 months
- ECOG 0 or 1
- All patients must give written informed consent indicating their understanding of the investigational nature and risks of the study before any protocol related studies are performed
Exclusion
- Contraindications to salvage prostatectomy
- Previous rectal surgery for IBD or cancer such that an ileo-anal anastomosis is present.
- Radiological evidence of regional or distant metastases
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 12 2023
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00791115
Start Date
June 1 2008
End Date
May 12 2023
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2M9